HALISTER: Glaxo, Merck Ebola Vaccine Trials to Start in Liberia This Month

Glaxo, Merck Ebola Vaccine Trials to Start in Liberia This Month

Alert: HALISTER Source: BN (Bloomberg News)

Tickers GSK LN (GlaxoSmithKline PLC) MRK US (Merck & Co Inc) JNJ US (Johnson & Johnson) NLNK US (NewLink Genetics Corp)

People Marie-Paule Kieny (World Health Organization)

Topics Viral Illnesses

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283